FI851521L - Nya polypeptider med blodkoagulering haemmande verkan, foerfarande foer deras framstaellning eller utvinning, deras anvaendning och dessa innehaollande medel. - Google Patents

Nya polypeptider med blodkoagulering haemmande verkan, foerfarande foer deras framstaellning eller utvinning, deras anvaendning och dessa innehaollande medel.

Info

Publication number
FI851521L
FI851521L FI851521A FI851521A FI851521L FI 851521 L FI851521 L FI 851521L FI 851521 A FI851521 A FI 851521A FI 851521 A FI851521 A FI 851521A FI 851521 L FI851521 L FI 851521L
Authority
FI
Finland
Prior art keywords
deras
haemmande
blodkoagulering
polypeptider
utvinning
Prior art date
Application number
FI851521A
Other languages
English (en)
Finnish (fi)
Other versions
FI851521A0 (fi
Inventor
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI851521A0 publication Critical patent/FI851521A0/fi
Publication of FI851521L publication Critical patent/FI851521L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI851521A 1984-04-18 1985-04-16 Nya polypeptider med blodkoagulering haemmande verkan, foerfarande foer deras framstaellning eller utvinning, deras anvaendning och dessa innehaollande medel. FI851521L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
FI851521A0 FI851521A0 (fi) 1985-04-16
FI851521L true FI851521L (fi) 1985-10-19

Family

ID=25820510

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851521A FI851521L (fi) 1984-04-18 1985-04-16 Nya polypeptider med blodkoagulering haemmande verkan, foerfarande foer deras framstaellning eller utvinning, deras anvaendning och dessa innehaollande medel.

Country Status (18)

Country Link
US (1) US4668662A (fr)
EP (1) EP0158986B1 (fr)
JP (1) JP2552263B2 (fr)
KR (1) KR930000054B1 (fr)
AR (1) AR242800A1 (fr)
AU (1) AU580295B2 (fr)
CA (1) CA1271298A (fr)
DE (2) DE3438296A1 (fr)
DK (1) DK171824B1 (fr)
ES (3) ES542309A0 (fr)
FI (1) FI851521L (fr)
GR (1) GR850942B (fr)
HU (1) HU198085B (fr)
IE (1) IE60581B1 (fr)
IL (1) IL74948A (fr)
NO (1) NO851535L (fr)
PT (1) PT80301B (fr)
ZA (1) ZA852854B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FI96956C (fi) * 1985-04-11 1996-09-25 Hoechst Ag Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
EP0209061B1 (fr) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Peptides à activité anticoagulante, leur procédé de préparation, d'obtention, leur application et les agents les contenant
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
DE68919848T2 (de) * 1988-05-27 1995-05-04 Philadelphia Children Hospital Amphiphile peptide und deren verwendung.
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
EP0347376B1 (fr) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Polypeptides à activité anticoagulante
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
CA2035917C (fr) * 1990-02-13 2001-10-02 John L. Krstenansky Derives sulfonate, sulfate, phosphonate et phosphate stabilises de hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
EP0559647A1 (fr) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. COMPOSITION ET TRAITEMENT A L'AIDE DE PEPTIDES BIOLOGIQUEMENT ACTIFS ET D'ANTIBIOTIQUES INHIBANT LA GYRASE d'ADN
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
JP3111075B2 (ja) * 1990-07-24 2000-11-20 メレルダウファーマスーティカルズ インコーポレイテッド 抗凝固ペプチド
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
CA2120337A1 (fr) * 1991-10-16 1993-04-17 Michael A. Zasloff Composition et traitement avec des peptides biologiquement actifs et antibiotique
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
CN1124964A (zh) * 1993-06-11 1996-06-19 默里尔药物公司 三功能抗凝血酶和抗血小板的肽
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69624087T2 (de) 1996-01-31 2003-06-05 Sumitomo Bakelite Co Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
CA2744145A1 (fr) * 2008-11-19 2010-05-27 Avantor Performance Materials, Inc. Nouveaux milieux chromatographiques a base de ligands phenoxy alkyle et alcoxy ou phenoxy phenyl alkyle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
ATE78294T1 (de) * 1984-03-27 1992-08-15 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
CA1271298A (fr) 1990-07-03
EP0158986B1 (fr) 1993-09-15
ES542310A0 (es) 1985-12-16
GR850942B (fr) 1985-11-25
PT80301A (de) 1985-05-01
JPS60233098A (ja) 1985-11-19
AU4136485A (en) 1985-10-24
KR850007801A (ko) 1985-12-09
US4668662A (en) 1987-05-26
EP0158986A3 (en) 1988-09-21
ES8605772A1 (es) 1985-12-16
ES8605770A1 (es) 1985-12-16
HU198085B (en) 1989-07-28
PT80301B (de) 1987-02-10
DE3587576D1 (de) 1993-10-21
FI851521A0 (fi) 1985-04-16
ES8605771A1 (es) 1985-12-16
DK173985A (da) 1985-10-19
NO851535L (no) 1985-10-21
JP2552263B2 (ja) 1996-11-06
IL74948A0 (en) 1985-08-30
KR930000054B1 (ko) 1993-01-06
ZA852854B (en) 1985-11-27
ES542309A0 (es) 1985-12-16
EP0158986A2 (fr) 1985-10-23
HUT37806A (en) 1986-02-28
IE850983L (en) 1985-10-18
ES542311A0 (es) 1985-12-16
DK171824B1 (da) 1997-06-23
AU580295B2 (en) 1989-01-12
AR242800A1 (es) 1993-05-31
DE3438296A1 (de) 1985-11-07
IE60581B1 (en) 1994-07-27
IL74948A (en) 1989-09-10
DK173985D0 (da) 1985-04-17

Similar Documents

Publication Publication Date Title
FI851521A0 (fi) Nya polypeptider med blodkoagulering haemmande verkan, foerfarande foer deras framstaellning eller utvinning, deras anvaendning och dessa innehaollande medel.
FI860971A (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI862623A0 (fi) Nya 2-arylimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI854862A (fi) Nya pteridiner, foerfarande foer deras framstaellning och deras anvaendning saosom mellanprodukter eller saosom laekemedel.
FI864879A0 (fi) Nya tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI861153A (fi) Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning.
FI874323A (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI855080A0 (fi) Nya imidazoderivat, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI852796A0 (fi) Nya pyrimidinderivat, foerfarande foer deras framstaellning och dessa innehaollande kompositioner.
FI870274A (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI855081A (fi) Nya imidazoderivat, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI862723A (fi) Nya sackarider, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI854863A (fi) Nya imidazoderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI851089L (fi) Nya ytaktiva medel.
FI865190A (fi) Nya bensamider, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
FI871812A0 (fi) Nya benzotiazinonderivat, deras framstaellningsfoerfarande dessa innehaollande laekemedel och deras anvaendning.
FI853651A0 (fi) Nya hydroxitiaalkener, deras framstaellning och anvaendning.
FI862136A0 (fi) Nya derivat av bicykliska aminosyror, foerfarande foer deras framstaellning, dessa innehaollande medel och deras anvaendning.
FI875212A (fi) Nya aryloxi-3-amino-2-propanoler, deras framstaellning och anvaendning.
FI851612L (fi) Nya apovinkaminolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI862970A (fi) Nya 11-metylen-estr-15-ener, foerfaranden foer deras framstaellning och farmaceutiska kompositioner.
FI874172A (fi) Nya aryloxi-aminoalkaner, deras framstaellning och anvaendning.
FI854707A0 (fi) Nya piperazinderivat, foerfarande foer framstaellning och andvaendning av desamma.
FI873179A0 (fi) Nya tetrahydrobenzotiazolo -kinoliner, deras framstaellning och anvaendning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT